A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis

Previous studies have considered automated segmentation techniques to be unreliable, particularly in neurodegenerative diseases. However, in our study, we produced results comparable to those obtained with a manual segmentation process. While manual segmentation processes conducted by neuroradiologists remain the gold standard, we present evidence to the capabilities and advantages of using an automated process that includes the ability to segment white matter throughout the brain or analyze large datasets, which pose feasibility issues to fully manual processes. Future investigations should consider the use of artificial intelligence-based segmentation pipelines to determine their accuracy in GM1 gangliosidosis, lysosomal storage disorders, and other neurodegenerative diseases.

Authors

Institutions

Publication Details

Journal
NeuroSci
Published
2025-04-03
DOI
https://doi.org/10.3390/neurosci6020031
Citations
4
Primary Topic
Lysosomal Storage Disorders Research
Type
article
Field-Weighted Citation Impact
4.66

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis

Muhammad Yousef, Maria T. Acosta, Mohammed Salman Shazeeb, Jean M. Johnston et al.
4 citations
NeuroSci
Lysosomal Storage Disorders Research
4.66
article

A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis

Muhammad Yousef, Maria T. Acosta, Mohammed Salman Shazeeb, Jean M. Johnston, Cynthia J. Tifft, Anna Luisa Kühn, Christopher Zoppo, Connor Lewis, Josephine Kolstad, William A. Gahl, Zubir Rentiya, Ahmet Peker, Zeynep Vardar, Precilla D’Souza
article en
4 citations

Abstract

Previous studies have considered automated segmentation techniques to be unreliable, particularly in neurodegenerative diseases. However, in our study, we produced results comparable to those obtained with a manual segmentation process. While manual segmentation processes conducted by neuroradiologists remain the gold standard, we present evidence to the capabilities and advantages of using an automated process that includes the ability to segment white matter throughout the brain or analyze large datasets, which pose feasibility issues to fully manual processes. Future investigations should consider the use of artificial intelligence-based segmentation pipelines to determine their accuracy in GM1 gangliosidosis, lysosomal storage disorders, and other neurodegenerative diseases.

NeuroSciVol. 6(2)
Koç University (TR), University of Massachusetts Chan Medical School (US), McLean Hospital (US), National Human Genome Research Institute (US), National Institutes of Health Clinical Center (US), University of Virginia (US)
National Institutes of Health
Openalex Percentile: Top 6%
Lysosomal Storage Disorders Research
4.66
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.